IKBKE and breast carcinoma: Previous studies have suggested that IKKε is overexpressed in tumor tissue from a variety of human tumor types, such as breast cancer, non-small cell lung cancer, and pancreatic cancer, where it has been proposed as biomarker and potential therapeutic target [15-18].